Live feed11:05:00·571dPRReleasevia QuantisnowMerus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024ByQuantisnow·Wall Street's wire, on your screen.MRUS· Merus N.V.Health Care
